Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
The Phase 2 trial followed participants through 48 weeks of treatment but did not include an extended washout observation period comparable to longer post-trial data available for Semaglutide
Knowing the normal dose is important for both healthcare providers and patients
Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound
Description AOD9604 is a modified fragment of human growth hormone (hGH), specifically designed for reducing body fat and aiding in weight management
These are amino acid based nutrients that play roles in natural metabolic pathways, cellular function and general wellness
US$ 22.38
US$ 21.90
US$ 28.40
US$ 28.71
US$ 25.02
